drugset / Trial / NCT02969447

Management of Third-stage of Labor After Second Trimester Medical Pregnancy Termination

NCT02969447

Phase 4 Completed 27 enrolled University Hospital, Bordeaux
RandomizedParallel-groupOpen-labelPrevention

Summary

Prospective randomized trail which compare 2 regimens for third-stage management after second trimester medical pregnancy termination : 10UI intra venous oxytocin or no additional medication after fetal expulsion. Primary outcome was the incidence of placental retention.

Timeline

Start
2016-10-20
Primary completion
2017-08-04
Completion
2017-08-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 10 iu Intravenous

Indications